FORWARD FEATURES CALENDAR

Deals

Palatine-backed tranScrip makes key acquisition

tranScrip, a fast-growing contract drug development organisation which supports the development and lifecycle of medicines, and a portfolio company of UK mid-market private equity investor Palatine, has acquired Dublin-based Real Regulatory, a highly respected business specialising in European regulatory affairs, quality systems and compliance for medical products. The strategic acquisition

Grünenthal and NovaQuest to advance RTX global Phase III programme

Grünenthal and NovaQuest, a life science investment firm with a focus on biopharmaceuticals, are to advance the global clinical Phase III programme of Grünenthal’s asset resiniferatoxin (RTX). The investigational medicine is being developed with the aim of providing patients suffering from pain associated with osteoarthritis with a well-tolerated, non-opioid therapy

Blackfinch Ventures exits first portfolio company, Candidate.ID

Blackfinch Ventures, part of Blackfinch Group and one of the fastest growing VCs in the UK, has exited its investment in Candidate.ID, a specialist in marketing automation technology for recruitment. The move follows the acquisition of Candidate.ID by iCIMS, the US-based talent cloud company, resulting in a strong return for

Caterpillar secures GBP450,000 in funding round led by Jenson Funding Partners

Caterpillar, a digital rewards app for health promotion, education and behavioural change, has secured GBP450,000 in funding from investors including VC firm Jenson Funding Partners. The healthtech company will use the funds to add new features to the app, expand the range of loyalty schemes it offers, and for other

PE-backed InMedica and MediCA Group complete EUR100m merger

Private medial chain In Medica, a portfolio company of INVL Baltic Sea Growth Fund has completed a merger with MediCA Group in what is the largest combination in the Lithuanian healthcare clinic market to date. The newly combined company will have a turnover in the region of EUR90 million, with

My Telescope raises EUR2.5m in seed round led by Vandep Capital and Trind VC

Swedish market intelligence and search startup My Telescope has raised EUR2.5 million in seed funding led by Vendep Capital and Trind VC to help marketers and brands measure and predict long-term trends in demand creation following their strategic marketing investments. My Telescope will use the funding to accelerate its growth

Actis acquires UluÄŸ Energy Distribution and Retail Services Co from Limak Investment

Limak Investment and Actis, a global sustainable infrastructure investor, have completed a share transfer of UluÄŸ Energy Distribution and Retail Services Co (UluÄŸ). The Share Purchase Agreement, which was first signed in September 2021, has met the necessary requirements of the Turkish Competition Authority, the Republic of Turkey Energy Market

Main Capital Partners-backed Pointsharp acquires Cryptshare

Swedish cybersecurity specialist Pointsharp, backed by Main Capital Partners (Main), has made its second add-on deal with the acquisition of German-based secure communication specialist Cryptshare AG. Pointsharp enables companies to build a better, modern and more secure workplace. Main first invested in Pointsharp in 2020 to support the company in

VC-backed Invizius awarded major biomedical catalyst grant

Invizius Limited (Invizius), a VC-backed biotechnology company developing treatments to suppress unwanted innate immune responses, has been awarded a GBP1 million grant to bring H-Guard, its proprietary priming solution, designed to reduce the life-threatening inflammatory effects of haemodialysis, to the clinic. The funds will be used towards H-Guard’s First-in-Man safety

Events

12 November, 2026 – 5:00 pm

Directory Listings